SCHEMBL5455844

SCHEMBL5455844

COC(=O)c1ccc(COc2ccc3cc(-c4ccc(-c5ccccc5)n4Cc4ccc(C(F)(F)F)cc4)ccc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A5 Q9Y345 1/20 0.46
PTPN7 P35236 1/20 0.46
MAOB P27338 4/20 0.45
NR1H2 P55055 1/20 0.44
PTPN1 P18031 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 2/20 0.44
AR P10275 1/20 0.44
NPC1 O15118 1/20 0.44
BCL2L1 Q07817 1/20 0.43
MCL1 Q07820 1/20 0.43
PPARD Q03181 2/20 0.43
PSEN1 P49768 1/20 0.43
ALOX5AP P20292 1/20 0.43
RAB9A P51151 1/20 0.43
PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5455835 0.91 NR4A2 (0.48) SLC6A5MAOBPTPN1MAPTNPC1
SCHEMBL5454538 0.90 NR1H2 (0.44) SLC6A5PTPN7NR1H2PPARDALOX5AP
SCHEMBL5442874 0.83 PPARD (0.50) PTPN7PTPN1PPARDALOX5APPPARA
SCHEMBL5455811 0.83 RXRA (0.46) SLC6A5NR1H2MCL1PPARDALOX5AP
SCHEMBL5451042 0.82 GRIK1 (0.44) MAOBMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL5451074 0.81 KDM4E (0.53) PTPN7PTPN1MEN1KMT2ASMN1; SMN2
SCHEMBL5442953 0.79 PPARG (0.49) PTPN1PPARA
SCHEMBL5446217 0.78 ESR1 (0.46) MEN1KMT2A
SCHEMBL5447426 0.78 PGR (0.39) MAOBMEN1KMT2AMAPTPPARD
SCHEMBL5448677 0.76 PPARG (0.61) PTPN1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM WYETH (US) 2007-05-31 US disclosed
EP-1781641-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS Wyeth (US) 2007-05-09 EP disclosed
US-7186749-B2 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2007-03-06 US disclosed
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them WYETH (US) 2006-03-09 US disclosed
WO-2006023864-A1 PYRROLO-NAPHTHYL ACIDS AS PAI-1 INHIBITORS WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123495-A1 PYRROLO-NAPHTHYL ACIDS AND METHODS FOR USING THEM SERPINE1, SERPINC1, SERPINB1 SLC6A5 4621/4885PTPN7 3293/4885MAOB 375/4885
US-20060052349-A1 Pyrrolo-naphthyl acids and methods for using them SERPINE1, SERPINC1, SERPINB1 SLC6A5 4621/4885PTPN7 3293/4885MAOB 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.